纳斯达克： -- -- --

最近浏览

实时行情

意见反馈

德康医疗

NASDAQ:DXCM 延时15分钟
  • 今开：--
    昨收：--
  • 今日区间：--
    52周区间：--
  • 成交量：--
    成交额：--
  • 市 值：--
    市盈率：--
  • 振幅：
    每股收益：
成交量

董事会

Kevin Ronald Sayer
Kevin Ronald Sayer is Executive Chairman at DexCom, Inc. since 2026 and Director at Medical Device Innovation Consortium since 2021. Former roles include Independent Director at Akesis Pharmaceuticals, Inc., Chief Financial Officer at MiniMed, Inc. from 1994 to 2001, Chief Financial Officer & Executive Vice President at Specialty Laboratories, Inc. from 2004 to 2005, Chief Financial Officer & Secretary at Biosensors International Group Ltd. in 2010, and Vice President & General Manager at Medtronic MiniMed, Inc. from 2001 to 2002. Education includes undergraduate and graduate degrees from Brigham Young University.
Kevin Ronald Sayer
Kevin Ronald Sayer is Executive Chairman at DexCom, Inc. since 2026 and Director at Medical Device Innovation Consortium since 2021. Former roles include Independent Director at Akesis Pharmaceuticals, Inc., Chief Financial Officer at MiniMed, Inc. from 1994 to 2001, Chief Financial Officer & Executive Vice President at Specialty Laboratories, Inc. from 2004 to 2005, Chief Financial Officer & Secretary at Biosensors International Group Ltd. in 2010, and Vice President & General Manager at Medtronic MiniMed, Inc. from 2001 to 2002. Education includes undergraduate and graduate degrees from Brigham Young University.
Nicholas Augustinos
Mr. Nicholas Augustinos is an Adviser at California HealthCare Foundation, a Chairman at Aver, Inc. and an Independent Director at DexCom, Inc. He is on the Board of Directors at California HealthCare Foundation and DexCom, Inc. Mr. Augustinos was previously employed as a SVP-Health Information Services & Strategy by Cardinal Health, Inc., a Senior Director-Global Healthcare Operations by Cisco Systems, Inc., a Partner by CSC, Inc., a Vice President-Care Data Exchange by CareScience, Inc., a Vice President by WebMD Corp., a Vice President by WebMD Health Corp., a Vice President-Administration by Clinishare Pharmacy, Inc., and a Senior Manager by Deloitte Consulting LLP. He also served on the board at Audax Health Solutions LLC, Audax Health Solutions, Inc., The SCAN Foundation and Continua Health Alliance. He received his undergraduate degree from National & Kapodistrian University of Athens, an undergraduate degree from King's College London and an MBA from the University of Michigan.
Jacob S. Leach
Jacob S. Leach is President, Chief Executive Officer & Director at DexCom, Inc. since 2026 and Independent Director at SenesTech, Inc. since 2020. Formerly, Mr. Leach was Head of Research & Development at MiniMed, Inc. from 1996 to 2004. Education includes undergraduate studies at the University of California, Los Angeles.
Steven R. Altman
Steven R. Altman was the founder of Prospector Capital Corp., founded in 2020, where the title held was Chairman from 2021 to 2023. Mr. Altman is also the founder of Local Music LLC.. Mr. Altman is currently an Independent Director at DexCom, Inc. since 2013. Mr. Altman is a Director at Brain Corp. (US) since 2016. Mr. Altman is a Director at Amionx, Inc. Mr. Altman is a Director at Course Key, Inc. Mr. Altman is a Director at Yembo, Inc. Mr. Altman is a Trustee at The Salk Institute for Biological Studies. Mr. Altman is a Managing Member at AJL Investments LLC. Former positions include Vice Chairman at QUALCOMM, Inc. from 2011 to 2014. Director at Amylin Pharmaceuticals, Inc. from 2006 to 2010. Director at ViaCyte, Inc. Director at JDRF International. Director at CONNECT. Independent Director at Ubiquiti, Inc. in 2015. President at QTL Biosystems LLC from 2000 to 2005. Attorney at Gray Cary Ames & Frye. Member at the University of California San Diego. Trustee at California Healthcare Institute. Education includes an undergraduate degree from Northern Arizona University conferred in 1983 and a graduate degree from the University of San Diego School of Law conferred in 1986.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Mark G. Foletta
Mark G. Foletta currently serves as Chairman at AMN Healthcare Services, Inc. since 2025, Lead Independent Director at DexCom, Inc. since 2015, Independent Director at Enanta Pharmaceuticals, Inc. since 2020, and is a Member of The Financial Executives Institute and Corporate Directors Forum. Former positions include Independent Director at Anadys Pharmaceuticals, Inc. in 2011, Director at ViaCyte, Inc. from 2013 to 2022, Independent Director at Ambit Biosciences Corp. in 2014, Independent Director at Regulus Therapeutics, Inc. from 2014 to 2018, Director at Islet Sciences, Inc. in 2013, Chief Financial Officer & Senior VP-Finance at Amylin Pharmaceuticals, Inc. from 2006 to 2012, Audit Manager at Ernst & Young LLP from 1986 to 2000, Chief Financial Officer at Biocept, Inc. from 2015 to 2016, Chief Financial Officer & Executive Vice President at Tocagen, Inc. from 2017 to 2020, Chief Financial Officer, Secretary & Senior VP at Intermark, Inc. from 1986 to 1997, Chief Financial Officer, Secretary & Senior VP at Triton Group Ltd. in 1997, and Principal at Triton Group Management, Inc. from 1997 to 2000. Education includes undergraduate studies at the University of California, Santa Barbara.
Richard Alexander Collins
Richard Alexander Collins is an Independent Director at DexCom, Inc. since 2017. Formerly, Mr. Collins was Chief Executive Officer at Golden Rule Insurance Co. from 2005 to 2012 and Chairman & Chief Executive Officer at Golden Rule Financial Corp. during the same period. Mr. Collins was President & Director at Mid Atlantic Medical Services LLC, Oxford Health Plans LLC, and UnitedHealthcare Insurance Company of New York. Mr. Collins served as Director at the National Association of Corporate Directors, UnitedHealthcare Children's Foundation, Inc., The Council for Affordable Health Insurance, The Nature Conservancy In Indiana, and Fairbanks Addiction Treatment & Recovery Center. Mr. Collins was President-Individual Line at UnitedHealth Group, Inc. from 2005 to 2012. Mr. Collins completed undergraduate education at Maine Maritime Academy.
Bridgette P. Heller
Bridgette P. Heller was the founder of Heller Associates, Inc., founded in 2004, where the title held was Managing Partner from 2004 to 2005. Ms. Heller is the founder of Shirley Proctor Puller Foundation, founded in 2019, holding the title Chief Executive Officer & Director since 2019. Current jobs include Director at Newman's Own Foundation since 2021, Independent Non-Executive Director at Novartis AG since 2020, Independent Director at DexCom, Inc. since 2019, Director at Newman's Own, Inc. since 2020, Director at Market Track LLC since 2021, Independent Director at Aramark since 2021, Director at Integral Ad Science, Inc. since 2021, Trustee at Northwestern University, Trustee at Northwestern University Clinical & Translational Sciences Institute, and Partner at Seedfunders LLC. Former jobs include Chief Executive Officer at Chung's Foods, Inc. from 2003 to 2004; Chairman at Girls, Inc. from 2008 to 2012; Independent Director at Integral Ad Science Holding Corp. from 2021 to 2025; Independent Director at Tech Data Corp. from 2016 to 2020; Director at The ADT Security Corp. from 2012 to 2016; Director at PCA International, Inc. in 2005; President-Baby Global Business Unit at Johnson & Johnson from 2007 to 2010; President-Consumer Care & Executive VP at Merck & Co., Inc. from 2010 to 2015; Executive Vice President & GM-Coffee Division at Mondelez International, Inc. from 1985 to 2002; EVP & GM-North American Coffee Portfolio at Kraft Foods Group, Inc. from 1985 to 2002; President & Executive Vice President at Nutricia Holdings Plc from 2016 to 2019; Executive VP & President-Specialized Nutrition at Danone Nederland BV from 2017 to 2019; President at Merck-Consumer Care from 2010 to 2015; and President-Specialized Nutrition & Executive VP at Danone SA from 2017 to 2019. Education includes undergraduate degree from Northwestern University and an MBAistration from Kellogg School of Management conferred in 1985.
Kyle J. Malady
Kyle J. Malady is Group CEO-Verizon Business & Executive VP at Verizon Communications, Inc. since 2023. Mr. Malady is Group Chief Executive Officer at Verizon Business Global LLC since 2023. Mr. Malady is Chairman at CTIA-The Wireless Association since 2025. Mr. Malady is Independent Director at DexCom, Inc. since 2020. Former roles include Director at Nitronex LLC, Vice President-Technology Development at Verizon Wireless, Inc., and Principal at Nynex Mobile Communications. Education includes undergraduate studies at the University of Bridgeport and an MBA from The Leonard N Stern School of Business.
Rimma Driscoll
Ms. Rimma Driscoll is an Independent Director at DexCom, Inc. and an EVP, Head-Global Strategy & Business Development at Zoetis, Inc. She is on the Board of Directors at DexCom, Inc., Pumpkin Insurance Services, Inc. and Licensing Executives Society. She received her undergraduate degree from Bowling Green State University and an MBA from Williams College of Business.
Euan A. Ashley
Euan A. Ashley is the founder of Deepcell, Inc. (founded in 2012), Swift Biosciences, Inc. (founded in 2025), Personalis, Inc. (founded in 2012), and Silicon Valley Exercise Analytics, Inc. (founded in 2019), where Dr. Ashley holds the title of Chairman since 2019. Current jobs include Chairman-Medicine Department at Stanford University since 2024, Independent Non-Executive Director at AstraZeneca PLC since 2020, Independent Director at DexCom, Inc. starting in 2025, and Advisor at Medical Excellence Capital LLC. Former job includes Director at Stanford Health Care. Education history includes undergraduate and doctorate degrees from the University of Glasgow and a doctorate degree from the University of Oxford conferred in 2002.
Albert Frederick Osterloh
Albert Frederick Osterloh is currently an Independent Director at DexCom, Inc. starting in 2026, Senior Vice President-Devices & Services at Google LLC, and an Advisor at KittyHawk Ventures LLC. Former positions include Director at First Republic Bank (San Francisco, California), Director at World Business Chicago, Board of Directors member at Positive Coaching Alliance from 2015 to 2021, Director at Lytro, Inc., Vice President at Visto Corp. from 2000 to 2007, Vice President at Skype SARL from 2010 to 2012, and President & Chief Operating Officer at Motorola Mobility LLC from 2014 to 2016. Education includes undergraduate and graduate degrees from Stanford University and an MBA from Stanford Graduate School of Business.